DISEASE INDICATIONS: HIV/AIDS
MANUFACTURER: ViiV Healthcare
MEDICINE APPROVED BY:
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Cabenuva is a combination medication used for the treatment of HIV-1 infection in adults who have already achieved viral suppression with a stable antiretroviral regimen. It is a novel therapy that offers a long-acting, injectable option for maintaining HIV suppression, offering potential benefits in terms of convenience and adherence.
